(Q36635544)

English

Flying under the radar: the immunobiology of hepatitis C.

scientific article published on January 2007

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

title

Flying under the radar: the immunobiology of hepatitis C. (English)

1 reference

stated in

Europe PubMed Central

15 August 2017

2

Charles M Rice

1 reference

stated in

Europe PubMed Central

15 August 2017

Lynn B Dustin

1

1 reference

stated in

Europe PubMed Central

15 August 2017

1 January 2007

1 reference

stated in

Europe PubMed Central

15 August 2017

Annual Review of Immunology

1 reference

stated in

Europe PubMed Central

15 August 2017

25

1 reference

stated in

Europe PubMed Central

15 August 2017

71-99

1 reference

stated in

Europe PubMed Central

15 August 2017

Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

MasterCARD: a priceless link to innate immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Cell culture models and animal models of viral hepatitis. Part II: hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C virus infection: when silence is deception.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Neutralizing antibody response during acute and chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

American Gastroenterological Association technical review on the management of hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Viruses and interferons

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Treatment of hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Epidemiology of hepatitis C: geographic differences and temporal trends

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

CD8 Epitope Escape and Reversion in Acute HCV Infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C and liver transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatic T cells and liver tolerance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Immunology. NK cells lose their inhibition

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Liver-directed gamma interferon gene delivery in chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Analysis of a successful immune response against hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Conserved hierarchy of helper T cell responses in a chimpanzee during primary and secondary hepatitis C virus infections

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

A target on the move: innate and adaptive immune escape strategies of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

CARD games between virus and host get a new player

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The original sin of killer T cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Oscillating CD8(+) T cell effector functions after antigen recognition in the liver.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Presence of functional dendritic cells in patients chronically infected with hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Memory CD8 T-cell differentiation during viral infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Novel insights into hepatitis C virus replication and persistence

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Extrahepatic manifestations of hepatitis C infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Noncytolytic control of viral infections by the innate and adaptive immune response

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Cell-mediated immunity and the outcome of hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Protection against persistence of hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Going both ways: immune regulation via CD1d-dependent NKT cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Heterologous T cell immunity in severe hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Humoral immune response in acute hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Unravelling hepatitis C virus replication from genome to function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Evasion of intracellular host defence by hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Adaptive immune responses in acute and chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The natural history of hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The influence of T cell cross-reactivity on HCV-peptide specific human T cell response.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Private aspects of heterologous immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Cross-genotype immunity to hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C kinetics: mathematical modeling of viral response to therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Pathogen recognition and innate immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

A critical role for the chimpanzee model in the study of hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

No one is naive: the significance of heterologous T-cell immunity.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Development of prophylactic and therapeutic vaccines against hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Global epidemiology of hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

CD8 T cell responses to viral infections in sequence

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Antibodies, viruses and vaccines

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Innate immune recognition of viral infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Immunity to hepatitis C virus: stunned but not defeated

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Cooperation between CD4+ and CD8+ T cells: when, where, and how.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Divergent and convergent evolution after a common-source outbreak of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Cellular immune selection with hepatitis C virus persistence in humans

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

The liver as an immunological organ

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Stealth and cunning: hepatitis B and hepatitis C viruses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1146/ANNUREV.IMMUNOL.25.022106.141602

Identifiers

DOI

10.1146/ANNUREV.IMMUNOL.25.022106.141602

1 reference

stated in

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

PubMed ID

17067278

retrieved

15 August 2017

(Q36635544)

Flying under the radar: the immunobiology of hepatitis C.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)